3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Conditions
Carcinoma, Basal Cell
8
Medulloblastoma
6
Recurrence
4
Skin Neoplasms
3
Basal Cell Nevus Syndrome
3
Thrombocythemia, Essential
2
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Glioma
2
Glioblastoma
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Astrocytoma
2
Thrombocytosis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Diseases
1
Interventions
Paclitaxel
95
Carboplatin
77
pembrolizumab
74
Cisplatin
29
Bevacizumab
27
Letrozole
22
Radiotherapy
21
Doxorubicin
21
Megestrol Acetate
20
lenvatinib
19
olaparib
18
Taxes
17
Docetaxel
17
Nivolumab
16
Specimen Handling
15
Metformin
15
dostarlimab
14
Magnetic Resonance Spectroscopy
14
Gemcitabine
13
durvalumab
12
Medroxyprogesterone Acetate
12
Trastuzumab
11
Indocyanine Green
11
Fulvestrant
11
Biopsy
11
temsirolimus
10
abemaciclib
10
atezolizumab
9
Radiation
9
Early Intervention, Educational
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Endometrial Neoplasms
×
sonidegib
×
Clear all
NCT02002689
2016-05-02
SIGNATURE
Novartis
Phase 2
Terminated
10 enrolled
9 charts